Drug price to cut when its unfair trade identified in the market.

Published: 2000-09-25 09:07:00

Updated: 2000-09-25 09:07:00

The KPMA worried that some drug companies were exercising unfair trade activities with medical institutes, by providing a special rebate to them in return of more prescribing their own products, and therefore made it clear by announcing on Sept. 19 that strict administrative measures including pr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK